Perrot Duval Holding (PEDU) Fair Value & Analysis
Industrials · CH · Market cap CHF 6.2M
Fair value as of: Jun 25, 2026
Analysis
Perrot Duval Holding (PEDU) currently trades at CHF 50.00, while our model-based Fair Value estimate is CHF 12.09 — implying the stock looks roughly 75.8% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Perrot Duval Holding S.A., together with its subsidiaries, provides automation technologies in the fields of process automation and chemical cosmetics worldwide. It operates through Automated Production Processes and Chemical Cosmetics Activity segments. The company develops, produces, and sells various original technological components and solutions. It supplies automated systems and components for dispensing and safety for processes in manufacturing chemical products, such as paints, varnishes, printing inks, food, and cosmetics, fragrances and flavors, fine chemicals, printing, packaging, adhesives, sealants, solvents, and binders, as well as pharmaceutical production. The company also manufactures decorative cosmetic products, including nail gels and lacquers for international wholesalers and professional studios. The company was founded in 1896 and is based in Geneva, Switzerland.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Perrot Duval Holding (PEDU) undervalued?
What is the fair value of PEDU?
What is the quality score of PEDU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.